CID 60919

Tasosartan

Structural Information

Molecular Formula
C23H21N7O
SMILES
CC1=C2CCC(=O)N(C2=NC(=N1)C)CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5
InChI
InChI=1S/C23H21N7O/c1-14-18-11-12-21(31)30(23(18)25-15(2)24-14)13-16-7-9-17(10-8-16)19-5-3-4-6-20(19)22-26-28-29-27-22/h3-10H,11-13H2,1-2H3,(H,26,27,28,29)
InChIKey
ADXGNEYLLLSOAR-UHFFFAOYSA-N
Compound name
2,4-dimethyl-8-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-5,6-dihydropyrido[2,3-d]pyrimidin-7-one
Related CIDs

2D Structure

compound 2d structure
5
Annotation Hits

29
References

14919
Patents

411.18076 Da
Monoisotopic Mass

3.0
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 412.18804 206.7
[M+Na]+ 434.16998 216.0
[M-H]- 410.17348 210.4
[M+NH4]+ 429.21458 208.9
[M+K]+ 450.14392 205.3
[M+H-H2O]+ 394.17802 192.0
[M+HCOO]- 456.17896 216.7
[M+CH3COO]- 470.19461 212.7
[M+Na-2H]- 432.15543 206.7
[M]+ 411.18021 204.5
[M]- 411.18131 204.5
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.